Literature DB >> 16094718

Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactor.

Qing Liu1, Zheng Liu, Evangelos Dalakas.   

Abstract

AIM: To determine the prevalence of porcine endogenous retrovirus (PERV) in various pig breeds raised in China including Chinese experimental mini-pigs by PERV-reverse transcriptase (PERV-RT enzyme). Moreover, the potential for infection of PERV was investigated in patients treated with a bioreactor based on porcine liver cells (n = 3).
METHODS: Pig serum, liver and muscle cell-free supernatants were collected from various Chinese pig breeds. Porcine hepatocytes were isolated with a two-step perfusion method. Three patients with acute or chronic liver failure were treated with a bioartificial liver support system (BALSS) for 8-12 h and serum samples were collected from the patients before, immediately after and 30 d after treatment.
RESULTS: The activities of PERV-RT enzyme in pig liver and muscle cell-free supernatants were higher than in normal human controls. PERV-TR enzyme activity did not increase in patients before and after 1 mo of treatment. PERV-RT activities were not significantly different when compared with pre-treatment group (1.544+/-0.155576), the post-treatment groups (1.501+/-0.053507, 1.461+/-0.033808 and 1.6006667+/-0.01963 for 0, 14 and 30 d post-treatment, respectively, P>0.05), and normal control group (1.440+/- 1.0641, P>0.05). RT enzyme activity in Chinese experimental mini-pigs was higher than in normal human control group (1.440+/-1.0641 U/mL, P<0.05), and not significantly different (P>0.05) when compared with the pig breeds except in the muscle supernatants. All the samples including muscle and liver cell supernatants from the Chinese mini-experimental pigs and the four domestic Chinese pig breeds contained PERVs.
CONCLUSION: These results suggest that the risk of PERV infection through BALSS containing porcine liver cells without immunosuppressants may be quite low. Although there were PERVs in Chinese experimental mini-pigs and porcine liver cell culture suspensions, we did not find any evidence of persistent PERV infection in patients treated with this porcine hepatocyte-based bioartificial liver.

Entities:  

Mesh:

Year:  2005        PMID: 16094718      PMCID: PMC4615419          DOI: 10.3748/wjg.v11.i30.4727

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Long-term follow-up failed to detect in vitro transmission of full-length porcine endogenous retroviruses from specific pathogen-free pig islets to human cells.

Authors:  B Clémenceau; D Jégou; L Martignat; P Saï
Journal:  Diabetologia       Date:  2001-11       Impact factor: 10.122

2.  Polymerase chain reaction assays for the diagnosis of infection with the porcine endogenous retrovirus and the detection of pig cells in human and nonhuman recipients of pig xenografts.

Authors:  W M Switzer; V Shanmugam; L Chapman; W Heneine
Journal:  Transplantation       Date:  1999-07-27       Impact factor: 4.939

3.  Viral hepatitis-related acute liver failure.

Authors:  Frank Vinholt Schiødt; Timothy J Davern; A Obaid Shakil; Brendan McGuire; Grace Samuel; William M Lee
Journal:  Am J Gastroenterol       Date:  2003-02       Impact factor: 10.864

4.  Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.

Authors:  Achilles A Demetriou; Robert S Brown; Ronald W Busuttil; Jeffrey Fair; Brendan M McGuire; Philip Rosenthal; Jan Schulte Am Esch; Jan Lerut; Scott L Nyberg; Mauro Salizzoni; Elizabeth A Fagan; Bernard de Hemptinne; Christoph E Broelsch; Maurizio Muraca; Joan Manuel Salmeron; John M Rabkin; Herold J Metselaar; Daniel Pratt; Manuel De La Mata; Lawrence P McChesney; Gregory T Everson; Philip T Lavin; Anthony C Stevens; Zorina Pitkin; Barry A Solomon
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

Review 5.  Xenotransplantation and pig endogenous retroviruses.

Authors:  Saema Magre; Yasuhiro Takeuchi; Birke Bartosch
Journal:  Rev Med Virol       Date:  2003 Sep-Oct       Impact factor: 6.989

6.  Porcine endogenous retroviruses (PERVs) and xenotransplantation: screening for transmission in several clinical trials and in experimental models using non-human primates.

Authors:  J Denner
Journal:  Ann Transplant       Date:  2003       Impact factor: 1.530

7.  Role of complement in xenotransplantation.

Authors:  Tom Eirik Mollnes; A E Fiane
Journal:  Allergy       Date:  2002       Impact factor: 13.146

Review 8.  Xenogeneic transplantation of porcine islets: an overview.

Authors:  Debra A MacKenzie; Debra A Hullett; Hans W Sollinger
Journal:  Transplantation       Date:  2003-09-27       Impact factor: 4.939

Review 9.  Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience.

Authors:  Andreas Pascher; Igor M Sauer; Claus Hammer; Joerg C Gerlach; Peter Neuhaus
Journal:  Xenotransplantation       Date:  2002-09       Impact factor: 3.907

Review 10.  Pig endogenous retroviruses and xenotransplantation.

Authors:  Jürgen H Blusch; Clive Patience; Ulrich Martin
Journal:  Xenotransplantation       Date:  2002-07       Impact factor: 3.907

View more
  3 in total

1.  Influence of chitosan nanofiber scaffold on porcine endogenous retroviral expression and infectivity in pig hepatocytes.

Authors:  Bing Han; Xiao-Lei Shi; Jiang-Qiang Xiao; Yue Zhang; Xue-Hui Chu; Jin-Yang Gu; Jia-Jun Tan; Zhong-Ze Gu; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

2.  Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: a experimental study.

Authors:  Bing Han; Xiao-Lei Shi; Yue Zhang; Xue-Hui Chu; Jin-Yang Gu; Jiang-Qiang Xiao; Hao-Zhen Ren; Jia-Jun Tan; Zhong-Ze Gu; Yi-Tao Ding
Journal:  Eur J Med Res       Date:  2012-05-25       Impact factor: 2.175

Review 3.  Porcine endogenous retroviruses in xenotransplantation--molecular aspects.

Authors:  Magdalena C Kimsa; Barbara Strzalka-Mrozik; Malgorzata W Kimsa; Joanna Gola; Peter Nicholson; Krzysztof Lopata; Urszula Mazurek
Journal:  Viruses       Date:  2014-05-13       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.